Search

Displaying results 8021 - 8030 of 10000 in total
  1. Drug

    Metrenperone

    go.drugbank.com/drugs/DB21312
    Experimental

    Metrenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Metrenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  2. Drug

    Acefylline clofibrol

    go.drugbank.com/drugs/DB21353
    Experimental

    Acefylline clofibrol is a small molecule drug. The usage of the INN stem '-fylline' in the name indicates that Acefylline clofibrol is a N-methylated xanthine derivative.

  3. Drug

    Sofnobrutinib

    go.drugbank.com/drugs/DB21626
    Experimental

    Sofnobrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  4. Drug

    Lacutoclax

    go.drugbank.com/drugs/DB21657
    Investigational

    Lacutoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  5. Drug

    Mindoperone

    go.drugbank.com/drugs/DB20001
    Experimental

    Mindoperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Mindoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  6. Drug

    Timiperone

    go.drugbank.com/drugs/DB20070
    Experimental

    Timiperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Timiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  7. Drug

    Vilzemetkib

    go.drugbank.com/drugs/DB21704
    Experimental

    Vilzemetkib is a small molecule drug. The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.

  8. Drug

    Pamrevlumab

    go.drugbank.com/drugs/DB14952
    Investigational

    Pamrevlumab is under investigation in clinical trial NCT00913393 (Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy).

  9. Drug

    Tefibazumab

    go.drugbank.com/drugs/DB16378
    Investigational

    Tefibazumab is under investigation in clinical trial NCT00198289 (Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs).

  10. Drug

    Garivulimab

    go.drugbank.com/drugs/DB16670
    Investigational

    Garivulimab is under investigation in clinical trial NCT03379259 (Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors).